Abstract
The mammalian host defence system can be divided broadly into adaptive and non-adaptive immunity. Adaptive immunity is acquired and is mediated by B and T lymphocytes. Non-adaptive immunity is mediated in part by a small subclass of heterogeneous peripheral blood mononuclear cells. This population, termed null cells, consists of haematopoietic precursors and cells mediating natural killer (NK) activity and antibody-dependent cellular cytotoxicity (ADCC). NK cells are a class of bon-adherent, non-phagocytic, rapidly cytotoxic lymphocytes which can efficiently lyse a wide variety of tumour cells1, virally infected cells2 and immature cell types of normal origin3. Despite the broad range of targets, only a limited number of specificities are thought to be involved in target-cell recognition4–6. Morphologically, NK cells are large granular lymphocytes7,8, but they have been shown to exhibit cell-surface markers characteristic of both T cells9–11 and monocytes12, raising doubt over their lineage. The recent cloning of the β-chain of the T-cell antigen receptor13,14 has now allowed us to investigate whether some NK celle are T-cell-related. We have examined rearrangement and expression of the β-chain of the T-cell receptor in cloned murine NK cell lines and fresh murine NK cell populations, and our results support the hypothesis that a subpopulation of NK cells is related to T cells and provide a basis for examining whether some NK activity is mediated by a small number of T-cell receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kiessling, R., Klein, E. & Wigzell, H. Eur. J. Immun. 5, 117–121 (1975).
Santoli, D., Trinchieri, G. & Leif, F. S. J. Immun. 121, 526–531 (1978).
Hansson, M., Kiessling, R., Anderson, B., Karre, K. & Roder, J. Nature 278, 174–176 (1979).
Phillips, W. H., Ortaldo, J. R. & Herberman, R. B. J. Immun. 125, 2322–2327 (1980).
Allavena, P. & Ortaldo, J. R. J. Immun. 132, 2363–2369 (1984).
Roder, J. C., Ahrlund-Richter, L. & Jondal, M. J. exp. Med. 150, 471–481 (1979).
Timonen, T., Ortaldo, J. R. & Herberman, R. B. J. exp. Med. 153, 569–581 (1981).
Timonen, T., Saksela, E., Ranki, A. & Hayry, P. Cell. Immun. 48, 133–148 (1979).
Perussia, B., Fanning, V. & Trinchieri, G. J. Immun. 131, 223–231 (1983).
Herberman, R. B., Nunn, M. E. & Holden, H. T. J. Immun. 121, 304–309 (1978).
West, W. H., Cannon, G. B., Kaye, H. D., Vonnard, G. D. & Herberman, R. B. J. Immun. 118, 355–361 (1977).
Zarling, J. M. & Kung, P. C. Nature 288, 394–396 (1980).
Yanagi, Y. et al. Nature 308, 145–149 (1984).
Hedrick, S. M., Nielson, E. A., Kavaler, J., Cohen, D. I. & Davis, M. M. Nature 308, 153–158 (1984).
Acha-Orbea, H., Groscurth, P., Lang, R., Stiz, L. & Hengartner, H. J. Immun. 130, 2952–2957 (1983).
Warner, J. F. & Dennert, G. Nature 300, 31–34 (1982).
Dennert, G., Yogeeswaran, G. & Yamagata, S. J. exp. Med. 153, 545–556 (1981).
Malissen, M. et al. Cell 37, 1101–1110 (1984).
Thomas, P. C. Proc. natn. Acad. Aci. U.S.A. 77, 5201–5205 (1980).
Yoshikai, Y. et al. Nature 312, 521–524 (1984).
Clark, S. et al. Nature 311, 387–389 (1984).
Siu, G. et al. Nature 311, 344–350 (1984).
Hercend, T. et al. J. exp. Med. 158, 1547–1560 (1983).
Blin, N. & Stafford, D. W. Nucleic Acids Res. 3, 2303–2308 (1976).
Rigby, P., Dieckmann, M., Rhodes, C. & Berg, P. J. molec. Biol. 113, 237–251 (1977).
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Caccia, N. et al. Cell 37, 1091–1099 (1984).
Beaumont, T. J. et al. Scand. J. Immun. 16, 123–133 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yanagi, Y., Caccia, N., Kronenberg, M. et al. Gene rearrangement in cells with natural killer activity and expression of the β-chain of the T-cell antigen receptor. Nature 314, 631–633 (1985). https://doi.org/10.1038/314631a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/314631a0
This article is cited by
-
From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
Cell Death & Differentiation (2021)
-
T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor ?, ?, or ? genes
Immunogenetics (1988)
-
Cell-mediated cytotoxicity in down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities
European Journal of Pediatrics (1988)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.